
0:00
NaN:NaN:NaN
A case in which the Court held that generic drug makers cannot be sued for not warning about potentially dangerous side effects on their drug labels, even when they follow federal rules that only require their labels to match those of their brand-name equivalents.
Flere episoder fra "U.S. Supreme Court 2010 Term Arguments"



Gå ikke glip af nogen episoder af “U.S. Supreme Court 2010 Term Arguments” - abonnér på podcasten med gratisapp GetPodcast.








